September 18th, 2024 (Shanghai) — We are glad to announce that Dr. Jacob Jacobsen, the Co-Founder & Chief Executive Officer of Evecxia Therapeutics, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About Evecxia Therapeutics
Evecxia is dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification, building a stronger more resilient endogenous serotonin system. Evecxia is Phase 2-ready with two unique drug candidates addressing large unmet needs in mood disorders:
• EVX-101: Oral tablet for next-line therapy in depression and obsessive-compulsive disorder patients responding inadequately to first-line SSRI antidepressants.
• EVX-301: IV infusion for patients hospitalized with suicidal ideation crisis.
EVX-101 and EVX-301 are risk-mitigated as efficacy and safety are founded in clinical data.
About the speaker
Dr. Jacobsen is the inventor of the Serotonin Synthesis Amplification pharmacological concept. Prior to joining Evecxia, initially as Chief Scientific Officer, he was a scientist at Duke University and Duke-National University Singapore, where he was the driver of a cross-disciplinary team executing seminal research on Serotonin Synthesis Amplification.
Previously, Dr. Jacobsen spent 8 years in drug discovery in pharma-biotech, NeuroSearch and Lundbeck. He is well-published, including in the highest ranking journals in Psychiatry, and is an inventor on all Evecxia issued and pending patents.
Dr. Jacobsen received his PhD in Neuropharmacology from the University of Copenhagen.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
REGISTER
To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 